Frontlight ResearchEarly access
CompletedNo phase
Retrospective Observational Study on GERD Management in General Hospitals in Korea
Key facts
- Who runs it
- Chong Kun Dang Pharmaceutical
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 13,750 people enrolled
- Started
- 3 Jan 2018
- Ended
- 31 Dec 2024
- Type of study
- Observational
- Record updated
- 16 May 2025
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Patients aged 19 years or older as of the date of their first visit
- Patients who visited domestic general hospitals (secondary and tertiary healthcare institutions) at least twice between January 1, 2018, and August 31, 2020, for the diagnosis or treatment of GERD
Who cannot take part
- Patients with no GERD treatment information recorded in the medical records, even once
- Patients deemed inappropriate for participation by the investigator (e.g., when the overall GERD diagnosis/treatment information is missing from the medical records)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and Its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea
- Record updated
- 16 May 2025